Results: 4

Comparison of the prognostic value of platelet-based prognostic models in patients with malignant hepatic tumors after TACE therapy

Acta cir. bras; 34 (7), 2019
Abstract Purpose: To investigate the prognostic value of 17 platelet-based prognostic scores in patients with malignant hepatic tumors after TACE therapy. Methods: In total, 92 patients were divided into death group and survival group according to long-term follow-up results. The AUC was calculated to ...

Negative serology of Fasciola hepatica infection in patients with liver cancer in Peru: a preliminary report

Abstract INTRODUCTION: The etiology of several hepatocellular carcinoma (HCC) cases remains largely unknown. Although Fasciola hepatica has been associated with liver fibrosis in Latin America, it has not yet been associated with HCC. This study aimed to determine the existence of specific IgG antibodie...

Serum leptin levens and hepatocellular carcinoma: review article

ABCD (São Paulo, Impr.); 29 (4), 2016
ABSTRACT Introduction: Hepatocellular carcinoma is one of the most frequent types of malignant tumors in the world. There is growing evidence of the relationship between it development and obesity. The mechanism that links obesity to cancer is still not fully understood; however, it is essential to the ...

Alfafetoproteína nos tumores de fígado e hepatopatias benignas
Alphafetoprotein in hepatic tumours and benign liver diseases

A alfafetoproteína (AFP) é uma proteína oncofetal que se eleva nä só no carcinoma hepatocelualr, mas também em metástases hepáticas e hepatopatias benignas. Objetivo. O conhecimento das alteraçöes de AFP, nestas doenças, facilitará a interpretaçäo dos resultados frente à suspeita de carcin...